Cargando…
Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study
BACKGROUND—: Studies assessing drug-coated balloons (DCB) for the treatment of femoropopliteal artery disease are encouraging. However, challenging lesions, such as severely calcified, remain difficult to treat with DCB alone. Vessel preparation with directional atherectomy (DA) potentially improves...
Autores principales: | Zeller, Thomas, Langhoff, Ralf, Rocha-Singh, Krishna J., Jaff, Michael R., Blessing, Erwin, Amann-Vesti, Beatrice, Krzanowski, Marek, Peeters, Patrick, Scheinert, Dierk, Torsello, Giovanni, Sixt, Sebastian, Tepe, Gunnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610565/ https://www.ncbi.nlm.nih.gov/pubmed/28916599 http://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.004848 |
Ejemplares similares
-
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
por: Steiner, Sabine, et al.
Publicado: (2020) -
The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2016) -
Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2017) -
Directional Atherectomy for Treating In-Stent Restenosis of the Superficial Femoral Artery
por: Cho, Sungsin, et al.
Publicado: (2020) -
IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial
por: Zeller, Thomas, et al.
Publicado: (2014)